SVP ramp-up delays due to regulatory approvals
SVP expansion targets inhalation solutions for export, but shape variation approvals can take 6-18 months, delaying revenue contribution.
AMANTA / bear-case history
Track the concerns that keep returning.
Amanta Healthcare · risk themes across the available quarters.
Research layer active
Bear-case history
Risks carried through the record.
medium
Working capital strain from inventory buildup
During Sterport ramp-up, inventory will accumulate for 3-5 months before sales catch up, potentially increasing working capital requirements.
Competitive capacity additions in two-port system
Competitors like Otsuka and Fresenius may convert existing lines to two-port systems, increasing supply and pressuring pricing.
EBITDA margin pressure from pre-emptive overheads
Management acknowledged that strengthening middle management and product development spending has temporarily pressured EBITDA margins.